Eltrekibart Study for Moderate to Severe Hidradenitis Suppurativa in Kentucky
10/1 — Be part of a clinical study in Kentucky evaluating the safety and efficacy of Eltrekibart for adults with moderate to severe Hidradenitis Suppurativa.
Ixekizumab and Tirzepatide for Plaque Psoriasis and Overweight Study in Kentucky
9/30 — Join our Kentucky study to explore the effects of Ixekizumab and Tirzepatide on individuals with plaque psoriasis and overweight.
Lutikizumab Study for Moderate to Severe Hidradenitis Suppurativa in Kentucky
9/15 — Participate in a clinical trial in Kentucky evaluating the safety and efficacy of Lutikizumab for adults and adolescents with moderate to severe Hidradenitis Suppurativa.
Rinvoq vs. Dupixent for Children Atopic Dermatitis Study in Kentucky
9/15 — Join our Phase 3 study in Kentucky comparing Upadacitinib and Dupilumab for children 6 to under 12 with moderate to severe atopic dermatitis.
Ruxolitinib Cream Study for Prurigo Nodularis in Kentucky
9/1 — Be part of our exciting clinical study in Kentucky for Prurigo Nodularis, focusing on the safety of maximal use of Ruxolitinib Cream.
Amlitelimab in Moderate-to-Severe Atopic Dermatitis Trial in Kentucky
Explore Amlitelimab, an innovative treatment for Atopic Dermatitis, in our COAST 2 clinical trial located in Kentucky.
